1. Home
  2. SWIN vs ELTX Comparison

SWIN vs ELTX Comparison

Compare SWIN & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SWIN
  • ELTX
  • Stock Information
  • Founded
  • SWIN 2017
  • ELTX 2011
  • Country
  • SWIN Hong Kong
  • ELTX United States
  • Employees
  • SWIN N/A
  • ELTX N/A
  • Industry
  • SWIN
  • ELTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • SWIN
  • ELTX Health Care
  • Exchange
  • SWIN Nasdaq
  • ELTX Nasdaq
  • Market Cap
  • SWIN 41.7M
  • ELTX 49.7M
  • IPO Year
  • SWIN 2023
  • ELTX 2021
  • Fundamental
  • Price
  • SWIN $2.51
  • ELTX $5.14
  • Analyst Decision
  • SWIN
  • ELTX Strong Buy
  • Analyst Count
  • SWIN 0
  • ELTX 3
  • Target Price
  • SWIN N/A
  • ELTX $9.50
  • AVG Volume (30 Days)
  • SWIN 105.8K
  • ELTX 28.2K
  • Earning Date
  • SWIN 11-29-2024
  • ELTX 11-13-2024
  • Dividend Yield
  • SWIN N/A
  • ELTX N/A
  • EPS Growth
  • SWIN N/A
  • ELTX N/A
  • EPS
  • SWIN N/A
  • ELTX N/A
  • Revenue
  • SWIN $3,437,000.00
  • ELTX N/A
  • Revenue This Year
  • SWIN N/A
  • ELTX N/A
  • Revenue Next Year
  • SWIN N/A
  • ELTX N/A
  • P/E Ratio
  • SWIN N/A
  • ELTX N/A
  • Revenue Growth
  • SWIN N/A
  • ELTX N/A
  • 52 Week Low
  • SWIN $2.01
  • ELTX $2.96
  • 52 Week High
  • SWIN $72.55
  • ELTX $11.45
  • Technical
  • Relative Strength Index (RSI)
  • SWIN 46.05
  • ELTX 52.50
  • Support Level
  • SWIN $2.15
  • ELTX $4.95
  • Resistance Level
  • SWIN $2.60
  • ELTX $5.81
  • Average True Range (ATR)
  • SWIN 0.23
  • ELTX 0.33
  • MACD
  • SWIN 0.00
  • ELTX 0.04
  • Stochastic Oscillator
  • SWIN 50.72
  • ELTX 49.43

About SWIN Solowin Holdings

Solowin Holdings Ltd is a investor-focused, versatile securities brokerage company in Hong Kong. It offers a wide spectrum of products and services through its secured one-stop electronic platform. It is engaged in providing securities related services, investment advisory service, and asset management service to customers. The operations were organized into four reportable segments: securities related services, investment advisory services, corporate consultancy services, and asset management services. It derives maximum revenue from investment advisory services.

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.

Share on Social Networks: